Lung cancer remains a global health challenge, and the treatment paradigm has been marked by a shift towards the adoption of precision medicine and immunotherapy. PTCE's 2026 Lung Cancer Day of Education will prepare oncology pharmacists to be leaders in facilitating biomarker testing and optimizing care across major subtypes. Save the date for a full-day of in-depth discussions covering resistance mechanisms, strategies to manage unique adverse effects, and optimal adherence to targeted oral therapies and immunotherapy regimens.
The full schedule with agenda details is coming soon.